Overall rank by patents
#24,736
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Mayfonk holds 11 US patents across 13 technology areas, rank #24,736 of 50,000 tracked assignees.
Mayfonk Athletic, Llc has been granted 11 US utility patents between 2015 and 2025, placing Mayfonk Athletic, Llc at rank #24,736 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Mayfonk Athletic, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Mayfonk sits between Masarykova Univerzita (11 patents, rank #24,732) and Mckeon Rolling Steel DOOR Co., Inc. (11 patents, rank #24,740) - the closest US assignees by grant volume. The composite Innovation Score of 37.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Mayfonk Athletic, Llc's 28.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mayfonk Athletic, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MASARYKOVA UNIVERZITA
11 patents
MASSACHUSETTS GENERAL HOSPITAL
11 patents
MATTUR HOLDINGS, INC.
11 patents
MAXINE M. THOMPSON TRUST
11 patents
MBRICO, LLC
11 patents
MCCI Corporation
11 patents
MCE 5 Development
11 patents
MCKEON ROLLING STEEL DOOR CO., INC.
11 patents
MAYFONK ATHLETIC, LLC
11 patents
What this shows Mayfonk holds 11 patents at rank #24,736, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Mayfonk's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 43% higher than 57% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2016 | 1 | 9.1% |
| 2018 | 2 | 18.2% |
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 2 | 18.2% |
| 2023 | 1 | 9.1% |
| 2025 | 1 | 9.1% |
Top 13 of 13 technology areas
Overall rank by patents
#24,736
Across all tracked assignees
37.7 out of 100
How to use this portfolio
Mayfonk's 11 grants land it in the top 43% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.